Your browser doesn't support javascript.
loading
Remdesivir induces persistent mitochondrial and structural damage in human induced pluripotent stem cell-derived cardiomyocytes.
Kwok, Maxwell; Lee, Carrie; Li, Hung Sing; Deng, Ruixia; Tsoi, Chantelle; Ding, Qianqian; Tsang, Suk Ying; Leung, Kam Tong; Yan, Bryan P; Poon, Ellen N.
Afiliación
  • Kwok M; Department of Medicine and Therapeutics, The Chinese University of Hong Kong (CUHK), Hong Kong SAR, China.
  • Lee C; Hong Kong Hub of Paediatric Excellence (HK HOPE), The Chinese University of Hong Kong (CUHK), Hong Kong SAR, China.
  • Li HS; Hong Kong Hub of Paediatric Excellence (HK HOPE), The Chinese University of Hong Kong (CUHK), Hong Kong SAR, China.
  • Deng R; Centre for Cardiovascular Genomics and Medicine, Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong (CUHK), Hong Kong SAR, China.
  • Tsoi C; Hong Kong Hub of Paediatric Excellence (HK HOPE), The Chinese University of Hong Kong (CUHK), Hong Kong SAR, China.
  • Ding Q; Centre for Cardiovascular Genomics and Medicine, Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong (CUHK), Hong Kong SAR, China.
  • Tsang SY; Department of Paediatrics, The Chinese University of Hong Kong (CUHK), Hong Kong SAR, China.
  • Leung KT; Hong Kong Hub of Paediatric Excellence (HK HOPE), The Chinese University of Hong Kong (CUHK), Hong Kong SAR, China.
  • Yan BP; Centre for Cardiovascular Genomics and Medicine, Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong (CUHK), Hong Kong SAR, China.
  • Poon EN; Hong Kong Hub of Paediatric Excellence (HK HOPE), The Chinese University of Hong Kong (CUHK), Hong Kong SAR, China.
Cardiovasc Res ; 118(12): 2652-2664, 2022 09 20.
Article en En | MEDLINE | ID: mdl-34609482
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Profármacos / Células Madre Pluripotentes Inducidas / Tratamiento Farmacológico de COVID-19 Límite: Animals / Humans Idioma: En Revista: Cardiovasc Res Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Profármacos / Células Madre Pluripotentes Inducidas / Tratamiento Farmacológico de COVID-19 Límite: Animals / Humans Idioma: En Revista: Cardiovasc Res Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido